Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis
- DOI
- 10.1007/s40120-026-00989-x
- Published
- 2026-07-16
- Container
- Neurology and Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40120-026-00989-x,
title = {Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis},
author = {Mahdi Barzegar and Sara Samadzadeh and Bertrand Audoin and Achim Berthele and Ayse Altintas and Barbara Willekens and Sini Laakso and Shima Jahani and Viktoria Papp and Clarissa Zappe and Antonia Lefter and Aksel Siva and Alireza Afshari-Safavi and Sören Möller and Beatrijs Wokke and Rosa Cortese and Zsolt Illes and Saif Huda and Rommer Paulus and Silvia Messina and Nicolas Collongues and Marius Ringelstein and Álvaro Cobo-Calvo and Yael Hacohen and Georgina Arrambide and Jacqueline Palace and Sara Mariotto and Romain Marignier and Ruth Geraldes and Friedemann Paul and Nasrin Asgari and Unknown},
year = {2026},
journal = {Neurology and Therapy},
doi = {10.1007/s40120-026-00989-x},
url = {https://doi.org/10.1007/s40120-026-00989-x}
}RIS
TY - JOUR TI - Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis AU - Mahdi Barzegar AU - Sara Samadzadeh AU - Bertrand Audoin AU - Achim Berthele AU - Ayse Altintas AU - Barbara Willekens AU - Sini Laakso AU - Shima Jahani AU - Viktoria Papp AU - Clarissa Zappe AU - Antonia Lefter AU - Aksel Siva AU - Alireza Afshari-Safavi AU - Sören Möller AU - Beatrijs Wokke AU - Rosa Cortese AU - Zsolt Illes AU - Saif Huda AU - Rommer Paulus AU - Silvia Messina AU - Nicolas Collongues AU - Marius Ringelstein AU - Álvaro Cobo-Calvo AU - Yael Hacohen AU - Georgina Arrambide AU - Jacqueline Palace AU - Sara Mariotto AU - Romain Marignier AU - Ruth Geraldes AU - Friedemann Paul AU - Nasrin Asgari AU - Unknown PY - 2026 JO - Neurology and Therapy DO - 10.1007/s40120-026-00989-x UR - https://doi.org/10.1007/s40120-026-00989-x ER -
APA
Barzegar, M., Samadzadeh, S., Audoin, B., Berthele, A., Altintas, A., Willekens, B., Laakso, S., Jahani, S., Papp, V., Zappe, C., Lefter, A., Siva, A., Afshari-Safavi, A., Möller, S., Wokke, B., Cortese, R., Illes, Z., Huda, S., Paulus, R., Messina, S., Collongues, N., Ringelstein, M., Cobo-Calvo, Á., Hacohen, Y., Arrambide, G., Palace, J., Mariotto, S., Marignier, R., Geraldes, R., Paul, F., Asgari, N., & Unknown (2026). Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis. Neurology and Therapy. https://doi.org/10.1007/s40120-026-00989-x
Source records
- crossref · retrieved 2026-09-25T11:31:34.789Z